Patients Return to Normal Activity Quickly
REMODEL randomized controlled trial shows that balloon dilation patients had a quicker recovery. On average, it took FESS patients 3 times longer to return to normal activities than balloon dilation patients.
REMODEL results affirm data from prior balloon dilation studies.
REMODEL data demonstrates how balloon dilation is better for patients, from a quicker return to normal activity to a differentiated recovery experience:
- Far fewer balloon patients were discharged with nasal bleeding.
- Only 8% of balloon patients required a post-operative debridement, versus 74% of FESS patients.
- FESS patients used prescription pain medication for an average of 2.8 days; balloon patients used prescription pain medication on average for less than one day.
Overall, REMODEL shows that treatment with balloons not only delivers comparable, significant and sustained symptom relief as FESS, it also delivers real patient benefits.
Standalone balloon dilation versus sinus surgery for chronic rhinosinusitis: A prospective, multicenter, randomized, controlled trial with 1-year follow-up
N. Bikhazi; J. Light; M. Schwartz; T. Truitt; J. Cutler; REMODEL Study Investigators. Am J Rhinol Allergy doi.org/10.2500/ajra.2014.28.4064.
Standalone balloon dilation versus sinus surgery for chronic rhinosinusitis: A prospective, multicenter, randomized, controlled trial.
Cutler J, Bikhazi N, Light J, Truitt T, Schwartz M. Am J Rhinol Allergy doi.org/10.2500/ajra.2013.27.3970.
Office-based balloon sinus dilation: a prospective, multicenter study of 203 patients.
Karanfilov B, Silvers S, Pasha R, Sikan A, Shikani A, Sillers MJ. Int Forum Allergy Rhinol. 2012 Nov 7; doi: 10.1002/alr.21112.
Two-year results: transantral balloon dilation of the ethmoid infundibulum.
Stankiewicz J, Truitt T, Atkins J, Winegar B, Cink P, Ravi J, Henderson D, Tami T. Intl Forum Allergy Rhinol. 2012 May-June; 2(3): 199-206.